Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (171-180 of 332) with videos related to

Pageof 34
Sort By:
BJU International|July 12, 2025
Sentinel lymph node staging in urological cancer surgery: advances in imaging, intra-operative detection and translational researchErik J van Gennep, Gijs H KleinJan, Teele Kuusk, et al.
BJUI Compass|August 28, 2023
A protocol for the development of core outcome sets for effectiveness trials and clinical audits in renal cell cancer (R-COS)Steven MacLennan, Lisa M Wintner, Katharina Beyer, et al.
Clinical Genitourinary Cancer|February 24, 2024
The Impact of a Multidisciplinary Tumor Board (MTB) on Treatment Decision Making for Patients With Renal Cell Carcinoma (RCC): 5-Year Data AnalysisLuna van den Brink, Annebeth E C Ruiter, Brunolf W Lagerveld, et al.
European Urology|June 26, 2019
Safe Use of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Urological Cancer: The European Association of Urology Position in 2019Marc-Oliver Grimm, Axel Bex, Maria De Santis, et al.
BJU International|November 13, 2018
Sentinel node biopsy in clinical stage I testicular cancer enables early detection of occult metastatic diseaseJoost M Blok, J Martijn Kerst, Erik Vegt, et al.
Frontiers in Oncology|February 7, 2019
Sources of Frustration Among Patients Diagnosed With Renal Cell CarcinomaCristiane Decat Bergerot, Dena Battle, Paulo Gustavo Bergerot, et al.
World Journal of Urology|April 13, 2024
The impact of the COVID-19 pandemic on renal cancer careHilin Yildirim, Adriaan D Bins, Corina van den Hurk, et al.
Future Oncology (London, England)|April 27, 2019
A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX)Axel Bex, Johan V van Thienen, Mariette Schrier, et al.
Cancers|September 28, 2021
Adherence to Treatment Guidelines and Associated Survival in Older Patients with Prostate Cancer: A Prospective Multicentre Cohort StudyAdolfo González Serrano, Claudia Martínez Tapia, Alexandre de la Taille, et al.
Physiological Genomics|April 26, 2007
Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissuesDorothe Hameyer, Ate Loonstra, Leonid Eshkind, et al.
Pageof 34

Showing results (171-180 of 332) with videos related to

Sort By:
Pageof 34
BJU International|July 12, 2025
Sentinel lymph node staging in urological cancer surgery: advances in imaging, intra-operative detection and translational researchErik J van Gennep, Gijs H KleinJan, Teele Kuusk, et al.
BJUI Compass|August 28, 2023
A protocol for the development of core outcome sets for effectiveness trials and clinical audits in renal cell cancer (R-COS)Steven MacLennan, Lisa M Wintner, Katharina Beyer, et al.
Clinical Genitourinary Cancer|February 24, 2024
The Impact of a Multidisciplinary Tumor Board (MTB) on Treatment Decision Making for Patients With Renal Cell Carcinoma (RCC): 5-Year Data AnalysisLuna van den Brink, Annebeth E C Ruiter, Brunolf W Lagerveld, et al.
European Urology|June 26, 2019
Safe Use of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Urological Cancer: The European Association of Urology Position in 2019Marc-Oliver Grimm, Axel Bex, Maria De Santis, et al.
BJU International|November 13, 2018
Sentinel node biopsy in clinical stage I testicular cancer enables early detection of occult metastatic diseaseJoost M Blok, J Martijn Kerst, Erik Vegt, et al.
Frontiers in Oncology|February 7, 2019
Sources of Frustration Among Patients Diagnosed With Renal Cell CarcinomaCristiane Decat Bergerot, Dena Battle, Paulo Gustavo Bergerot, et al.
World Journal of Urology|April 13, 2024
The impact of the COVID-19 pandemic on renal cancer careHilin Yildirim, Adriaan D Bins, Corina van den Hurk, et al.
Future Oncology (London, England)|April 27, 2019
A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX)Axel Bex, Johan V van Thienen, Mariette Schrier, et al.
Cancers|September 28, 2021
Adherence to Treatment Guidelines and Associated Survival in Older Patients with Prostate Cancer: A Prospective Multicentre Cohort StudyAdolfo González Serrano, Claudia Martínez Tapia, Alexandre de la Taille, et al.
Physiological Genomics|April 26, 2007
Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissuesDorothe Hameyer, Ate Loonstra, Leonid Eshkind, et al.
Pageof 34